United States · Investor

MedImmune Ventures

Last cheque observed Apr 2018. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietCorporate VC

Series BSeries ASeries CFitnessHealth Care

Cheques on record
0%of best year0cheques in 12 months, 46 on record
Since the last cheque3106days00hrs00min00sec
Median round$60MRounds led0 of 46Sole investor1 roundsExits6 from the portfolioMostly inUnited States, 97%
Pitch MedImmune Ventures

MedImmune Ventures highlights

  1. 01

    46 rounds on record

  2. 02

    Mostly Series B and Series A: 60% of its rounds

  3. 03

    Sole investor in 1 rounds, median $22M

  4. 04

    6 exits from the portfolio

What they do

Type
Corporate VC (from a list, unverified)
Cheque size
Not stated
Sectors
FitnessHealth Care
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first46 appearances

  1. 2018

    1 round

  2. Apr
    CorvidiaSeries B · US · FinSMEs$60MWith 8 others
  3. 2015

    1 round

  4. Feb
    G1 Therapeutics, Inc.Series B · US$33MWith 5 others
  5. 2014

    2 rounds

  6. Nov
    MdBio FoundationGrant · US$500KWith 1 other
  7. Sept
    VentiRx PharmaceuticalsSeries B · US$51MWith 4 others
  8. 2013

    5 rounds

  9. Nov
    Catabasis PharmaceuticalsSeries B · US · finsmes.com$32MWith 4 others
  10. Oct
    G1 Therapeutics, Inc.Series A · US · finsmes.com$13MWith 2 others
  11. Oct
    ADC TherapeuticsVenture · SZ · unquote.com$40MWith 1 other
  12. Sept
    Inotek PharmaceuticalsDebt · US · inotekcorp.com$7.0MWith 5 others
  13. Feb
    Catabasis PharmaceuticalsVenture · US · fiercebiotech.com$9.0MWith 3 others
  14. 2012

    3 rounds

  15. Nov
    Applied Genetics Technologies CorporationSeries B · US · biospace.com$38MWith 5 others
  16. Nov
    Ambit BiosciencesVenture · US · phx.corporate-ir.net$50MWith 8 others
  17. Jul
    CoferonSeries B · US · marketwire.com$12MWith 2 others
  18. 2011

    3 rounds

  19. Dec
    Catabasis PharmaceuticalsSeries A · US · catabasispharma.com$8.0MWith 3 others
  20. Jul
    Inotek PharmaceuticalsSeries D · US · sec.gov$24MWith 4 others
  21. Jun
    Ambit BiosciencesSeries D · US · phx.corporate-ir.net$30MWith 9 others
  22. 2010

    3 rounds

  23. Jun
    Corridor PharmaceuticalsSeries A · US · finance.yahoo.com$13MWith 7 others
  24. Apr
    Catabasis PharmaceuticalsSeries A · US · fiercebiotech.com$39MWith 3 others
  25. Jan
    VentiRx PharmaceuticalsSeries A · US · fis.dowjones.com$25MWith 3 others
  26. 2009

    8 rounds

  27. Nov
    Virdante PharmaceuticalsSeries A · US · onbiovc.com$30MWith 6 others
  28. Oct
    Corridor PharmaceuticalsSeries A · US · venturedeal.com$11MWith 3 others
  29. Aug
    LigoCyte PharmaceuticalsSeries C · US$29MWith 3 others
  30. Jun
    VaxInnateSeries D · US · onbiovc.com$30MWith 6 others
  31. Jun
    Applied Genetics Technologies CorporationSeries C · US · onbiovc.com$12MWith 2 others
  32. Mar
    NKT TherapeuticsSeries A · US · bizjournals.com$8.0MWith 1 other
  33. Jan
    MelintaGrowth · US · rib-x.com$25MWith 7 others
  34. Jan
    Hydra BiosciencesSeries D · US · reuters.com$22MSole investor
  35. 2008

    4 rounds

  36. Oct
    Corridor PharmaceuticalsSeed · US · findarticles.com$2.3MWith 3 others
  37. Oct
    Seed · findarticles.com$2.3MWith 3 others
  38. Apr
    LigoCyte PharmaceuticalsSeries B · US$28MWith 3 others
  39. Mar
    BrainCellsSeries B · US · venturebeat.com$30MWith 5 others
  40. 2007

    4 rounds

  41. Nov
    Ambit BiosciencesSeries D · US$49MWith 11 others
  42. Oct
    Altiris TherapeuticsSeries B · US$35MWith 8 others
  43. Aug
    Inotek PharmaceuticalsSeries C · US$19MWith 4 others
  44. Jan
    Sequoia PharmaceuticalsSeries C · US · fiercebiotech.com$35MWith 4 others
  45. 2006

    4 rounds

  46. Oct
    VaxInnateSeries C · US · thefreelibrary.com$40MWith 5 others
  47. Aug
    Series A · highbeam.com$4.5MWith 20 others
  48. Jun
    VLST CorporationSeries B · US · vlstcorp.com$55MWith 6 others
  49. May
    AvidiaSeries C · US · freshnews.com$44MWith 6 others
  50. 2005

    2 rounds

  51. May
    AvidiaSeries B · US · thefreelibrary.com$29MWith 1 other
  52. Apr
    Receptor BiologixSeries A$34MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed6 in all

Ambit BiosciencesBought by Daiichi Sankyo$410MSept 2014
LigoCyte PharmaceuticalsBought by Takeda Pharmaceutical$60MOct 2012
AvidiaBought by Amgen$290MSept 2008
TercicaBought by Ipsen$480MJun 2008
Iomai CorporationBought by Intercell$186MMay 2008
Critical Therapeutics,Inc.Bought by Cornerstone TherapeuticsUndisclosedMay 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as MedImmune Ventures. A count of rooms they were both in, not a relationship either has claimed.

HealthCare VenturesGrowth equity6rounds togetherOxford Bioscience PartnersGrowth equity6rounds togetherAdvanced Technology VenturesVC firm5rounds togetherCare CapitalGrowth equity5rounds togetherClarus VenturesVC firm5rounds togetherForward VenturesAccelerator5rounds togetherQuaker PartnersVC firm5rounds togetherRed Abbey Venture PartnersVC firm5rounds togetherSV Life SciencesVC firm5rounds togetherAcidophilVC firm4rounds togetherDomain AssociatesVC firm4rounds togetherRho Capital PartnersPrivate equity4rounds together

Quick answers about MedImmune Ventures

What does MedImmune Ventures invest in?

MedImmune Ventures invests most often at Series B and Series A (60% of the rounds on record), in sectors such as Fitness and Health Care.

How active is MedImmune Ventures?

46 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2018.

What has MedImmune Ventures invested in recently?

Its most recent investments on record: Corvidia (Series B, Apr 2018).

How big are MedImmune Ventures's cheques?

The median round it joins is $60M.

Does MedImmune Ventures lead rounds?

Rarely, if at all: none of its 46 investments on record names it as the lead.

Where does MedImmune Ventures invest?

Most of the companies it backs are in the United States (97%).

Is MedImmune Ventures investing now?

No investments in the last 12 months; the latest was in Apr 2018.

Who does MedImmune Ventures invest alongside?

Most often HealthCare Ventures (6 rounds together), Oxford Bioscience Partners (6 rounds together) and Advanced Technology Ventures (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it